Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Minrad International was a pharmaceutical and medical device company specializing in the development and marketing of inhalation anesthetics and real-time image guidance systems. The company's primary product line included generic inhalation anesthetics such as isoflurane, sevoflurane, and enflurane, used globally in surgical procedures. Additionally, Minrad developed proprietary drug delivery systems and image-guided medical technologies for interventional radiology and orthopedics. In 2009, the company was acquired by Piramal Healthcare, significantly expanding Piramal's presence in the global critical care market. This acquisition provided Piramal with key manufacturing facilities in the United States and a robust portfolio of anesthetic products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Minrad International.